Lawrence Blacher, M.D., Memorial Lecture: Progress in AL Amyloidosis: Emerging Triumph Over Adversity
AL amyloidosis is a complex plasma cell disorder that poses significant diagnostic and therapeutic challenges. Please join us at this special event to hear renowned expert Vaishali Sanchorawala, M.D., provide an in-depth review of AL amyloidosis, including its pathophysiology, recent therapeutic advances, and evolving practice standards. Participants will explore strategies to enhance patient-centered care and assess clinical trial eligibility to optimize patient management and outcomes.
About Dr. Blacher
Dr. Lawrence Blacher was a pillar of the South Florida medical community. In practice for more than 40 years, he was instrumental in the founding and growth of Baptist Health Miami Cardiac & Vascular Institute and one of the original members of HeartWell, the Institute’s cardiology group. He was a strong advocate for the collaborative approach to medicine, contributing his expertise, guidance and wisdom.
A second-generation physician, Dr. Blacher took a personal approach to medicine and devoted his time and energy to listen and connect with his patients. He was a kind soul whose actions remind us that compassion and empathy are at the heart of medicine.
In late 2022, Dr. Blacher found himself on the other side of the doctor-patient relationship when he was diagnosed with AL amyloidosis, a rare disease presenting a constellation of symptoms that complicated his diagnosis and treatment. During his courageous final days, Dr. Blacher’s only wish was to increase awareness within the medical community about this cruel disease.
This program is a manifestation of his final wish. Today, we honor his memory and pay tribute to Dr. Blacher’s commitment to lifelong learning and to improving the outcomes for those with AL amyloidosis.
Learning Objectives
Upon completion of this conference, participants should be better able to:
- Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms.
- Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients.
- Implement strategies to enhance patient-centered care.
- Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral.
Who Should Attend
Cardiologists, hematologists, nephrologists, primary care physicians, general internists, neurologists, physician assistants, advanced practice registered nurses, hospitalists, nurses, pharmacists and techs, respiratory therapists and other interested healthcare providers.
Agenda
5:30 p.m. | Welcome Reception |
6:30 p.m. | Opening Remarks |
7:00 p.m. | CME Lecture |
8:00 p.m. | Adjourn |
Registration and Fees
This conference is offered free of charge.
5:30 – Welcome Reception
6:30 – Opening Remarks
7:00 – CME Lecture
8:00 - Adjourn
Faculty
Professor of Medicine
Director, Amyloidosis Center
Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine
Boston, MA
Disclosures And Resolution Of Conflict Of Interest
Vaishali Sanchorawala, M.D., faculty of this educational activity, receives grant/research support from Prothena, Abbvie, Janssen and Alexion/AstraZeneca; is a consultant for Eidos, Janssen, Abbvie and Prothena; and is an advisor for Protego and Alexion/AstraZeneca. Dr. Sanchorawala has indicated that the presentation or discussion will include off-label or unapproved product usage.
Sandra Chaparro, M.D., co-director of this educational activity, receives grant/research support from Cordio, Endotronix and Impulse Dynamics.
Jonathan Fialkow, M.D., co-director of this educational activity had nothing to disclose.
The following non-faculty contributors involved in the planning, development and editing/review of the content have relevant financial relationships to disclose with ineligible companies*:
- Barry T. Katzen, M.D. – Consultant for Philips, Gore and Boston Scientific.
- Tom C. Nguyen, M.D. – Advisor for Edwards Lifesciences
Others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for a total of 1 credit hours, CE Broker Course #20-1279054, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Techs and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy